Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4204887
Max Phase: Preclinical
Molecular Formula: C10H12BNO7S
Molecular Weight: 301.08
Molecule Type: Small molecule
Associated Items:
ID: ALA4204887
Max Phase: Preclinical
Molecular Formula: C10H12BNO7S
Molecular Weight: 301.08
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(O)c1cccc(CS(=O)(=O)C(=O)NCB(O)O)c1
Standard InChI: InChI=1S/C10H12BNO7S/c13-9(14)8-3-1-2-7(4-8)5-20(18,19)10(15)12-6-11(16)17/h1-4,16-17H,5-6H2,(H,12,15)(H,13,14)
Standard InChI Key: QHDNHPVOCKRDPE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 301.08 | Molecular Weight (Monoisotopic): 301.0428 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. González-Bello C.. (2017) Antibiotic adjuvants - A strategy to unlock bacterial resistance to antibiotics., 27 (18): [PMID:28827113] [10.1016/j.bmcl.2017.08.027] |
Source(1):